Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2010 3
2011 6
2012 2
2015 2
2016 2
2018 1
2019 3
2020 18
2021 22
2022 12
2023 15
2024 9
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Upadacitinib Reduces Crohn's Disease Symptoms Within the First Week of Induction Therapy.
Colombel JF, Hisamatsu T, Atreya R, Bresso F, Thin L, Panaccione R, Parra RS, Ford S, Remple VP, Lacerda AP, Anyanwu SI, Mallick M, Garrison A, Regueiro M. Colombel JF, et al. Among authors: parra rs. Clin Gastroenterol Hepatol. 2024 Aug;22(8):1668-1677. doi: 10.1016/j.cgh.2024.02.027. Epub 2024 Mar 15. Clin Gastroenterol Hepatol. 2024. PMID: 38492903 Free article. Clinical Trial.
Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study.
da Costa Ferreira S, Parra RS, Sassaki LY, Parente JML, de Mello MK, Chebli LA, Luporini RL, Alves Junior AJT, Firmino Nóbrega FJ, da Silva BC, Miranda EF, Quaresma AB, Nicollelli GM, Gasparini RG, Dutra RM, Vasconcelos JRO, da Silva KDC, Magro DO, Imbrizi MR, Nagasako CK, Féres O, Troncon LEA, Kotze PG, Chebli JMF. da Costa Ferreira S, et al. Among authors: parra rs. Gastroenterol Hepatol. 2025 Feb 21:502396. doi: 10.1016/j.gastrohep.2025.502396. Online ahead of print. Gastroenterol Hepatol. 2025. PMID: 39987969 Free article. English, Spanish.
Tofacitinib for ulcerative colitis in Brazil: a multicenter observational study on effectiveness and safety.
Parra RS, de Sá Brito Fróes R, Magro DO, da Costa Ferreira S, de Mello MK, de Azevedo MFC, Damião AOMC, de Sousa Carlos A, Barros LL, de Miranda MLQ, Vieira A, Sales MPM, Zabot GP, Cassol OS, Tiburcio Alves AJ Jr, Lubini M, Machado MB, Flores C, Teixeira FV, Coy CSR, Zaltman C, Chebli LA, Sassaki LY, Féres O, Chebli JMF. Parra RS, et al. BMC Gastroenterol. 2025 Mar 18;25(1):184. doi: 10.1186/s12876-025-03656-x. BMC Gastroenterol. 2025. PMID: 40102788 Free PMC article.
Impact of Upadacitinib Induction and Maintenance Therapy on Health-related Quality of Life, Fatigue, and Work Productivity in Patients with Moderately-to-severely Active Crohn's Disease.
Ghosh S, Feagan BG, Parra RS, Lopes S, Steinlauf A, Kakuta Y, Joshi N, Lee WJ, Lacerda AP, Zhou Q, Xuan S, Kligys K, Shukla N, Louis E. Ghosh S, et al. Among authors: parra rs. J Crohns Colitis. 2024 Nov 4;18(11):1804-1818. doi: 10.1093/ecco-jcc/jjae083. J Crohns Colitis. 2024. PMID: 38835235 Free PMC article. Clinical Trial.
The turning point of COVID-19 severity is associated with a unique circulating neutrophil gene signature.
Fuzo CA, Fraga-Silva TFC, Maruyama SR, Bastos VAF, Rogerio LA, Takamiya NT, da Silva-Neto PV, Pimentel VE, Toro DM, Pérez MM, de Carvalho JCS, Carmona-Garcia I, Oliveira CNS, Degiovani AM, Ostini FM, Constant LF, de Amorim AP, Vilar FC, Feitosa MR, Parra RS, da Rocha JJR, Feres O, Gaspar GG, Viana AL, Fernandes APM, Santos IKFM, Russo EMS, Cardoso CRB, Sorgi CA, Faccioli LH, Bonato VLD, Dias-Baruffi M; ImmunoCOVID study group. Fuzo CA, et al. Among authors: parra rs. Immunology. 2023 Jul;169(3):323-343. doi: 10.1111/imm.13631. Epub 2023 Mar 8. Immunology. 2023. PMID: 36740582 Free article.
93 results